Andrew Tsotinis

1.7k total citations
90 papers, 1.4k citations indexed

About

Andrew Tsotinis is a scholar working on Organic Chemistry, Molecular Biology and Endocrine and Autonomic Systems. According to data from OpenAlex, Andrew Tsotinis has authored 90 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Organic Chemistry, 26 papers in Molecular Biology and 17 papers in Endocrine and Autonomic Systems. Recurrent topics in Andrew Tsotinis's work include Circadian rhythm and melatonin (17 papers), Free Radicals and Antioxidants (14 papers) and Eicosanoids and Hypertension Pharmacology (13 papers). Andrew Tsotinis is often cited by papers focused on Circadian rhythm and melatonin (17 papers), Free Radicals and Antioxidants (14 papers) and Eicosanoids and Hypertension Pharmacology (13 papers). Andrew Tsotinis collaborates with scholars based in Greece, United Kingdom and United States. Andrew Tsotinis's co-authors include Peter J. Garratt, David Sugden, Theodora Calogeropoulou, Ioannis Papanastasiou, Athanasia Varvaresou, John M. Kelly, A Vamvakidès, Anna Tsantili‐Kakoulidou, Nicolas Kolocouris and Muy‐Teck Teh and has published in prestigious journals such as Chemical Communications, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Andrew Tsotinis

90 papers receiving 1.4k citations

Peers

Andrew Tsotinis

EAS

CMN

EPIDE

Theodora Calogeropoulou Greece

Javier Sastre Toraño Netherlands

Daniel‐Henri Caignard France

Steven M. Firestine United States

Tristan A. Reekie Australia

Simone Lucarini Italy

Philip A. Hipskind United States

John Saunders United States

David M. Shackleford Australia

David R. Witty United Kingdom

Theodora Calogeropoulou Greece

Andrew Tsotinis

840 ×0.9

741 ×1.9

89 ×0.4

EAS

219 ×1.6

CMN

210 ×1.7

EPIDE

Citations per year, relative to Andrew Tsotinis Andrew Tsotinis (= 1×) peers Theodora Calogeropoulou

Countries citing papers authored by Andrew Tsotinis

Since Specialization

Citations

This map shows the geographic impact of Andrew Tsotinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Tsotinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Tsotinis more than expected).

Fields of papers citing papers by Andrew Tsotinis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Tsotinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Tsotinis. The network helps show where Andrew Tsotinis may publish in the future.

Co-authorship network of co-authors of Andrew Tsotinis

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Tsotinis. A scholar is included among the top collaborators of Andrew Tsotinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Tsotinis. Andrew Tsotinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fytas, George, et al.. (2024). New Lipophilic Hydroxamates as Promising Trypanocidal Agents: Design, Synthesis, SAR, and Conformational Behavior Studies. ACS Medicinal Chemistry Letters. 15(7). 1041–1048. 1 indexed citations

Vlachou, Marilena, Stefanos Kikionis, Angeliki Siamidi, et al.. (2019). Development and Characterization of Eudragit®-Based Electrospun Nanofibrous Mats and Their Formulation into Nanofiber Tablets for the Modified Release of Furosemide. Pharmaceutics. 11(9). 480–480. 36 indexed citations

Vlachou, Marilena, Stefanos Kikionis, Angeliki Siamidi, et al.. (2018). Modified In Vitro Release of Melatonin Loaded in Nanofibrous Electrospun Mats Incorporated Into Monolayered and Three-Layered Tablets. Journal of Pharmaceutical Sciences. 108(2). 970–976. 26 indexed citations

Vlachou, Marilena, Angeliki Siamidi, Stefanos Kikionis, et al.. (2017). Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan. Journal of Drug Delivery Science and Technology. 44. 41–48. 25 indexed citations

Fytas, Christos, Grigoris Zoidis, Andrew Tsotinis, et al.. (2015). Novel 1-(2-aryl-2-adamantyl)piperazine derivatives with antiproliferative activity. European Journal of Medicinal Chemistry. 93. 281–290. 25 indexed citations

Tsotinis, Andrew, et al.. (2014). Benzocyclobutane, Benzocycloheptane and Heptene Derivatives as Melatonin Agonists and Antagonists. ChemMedChem. 9(10). 2238–2243. 14 indexed citations

Papanastasiou, Ioannis, George B. Foscolos, Andrew Tsotinis, et al.. (2012). New Adamantane Derivatives with Sigma Affinity and Antiproliferative Activity. Medicinal Chemistry. 8(4). 569–586. 19 indexed citations

Zoidis, Grigoris, Andrew Tsotinis, Nicolas Kolocouris, et al.. (2008). Design and synthesis of bioactive 1,2-annulated adamantane derivatives. Organic & Biomolecular Chemistry. 6(17). 3177–3177. 32 indexed citations

Andreadou, Ioanna, et al.. (2008). Alternative Pharmacological Interventions that Limit Myocardial Infarction. Current Medicinal Chemistry. 15(30). 3204–3213. 11 indexed citations

10.

Iliodromitis, Efstathios K., Maria Koufaki, Andrew Tsotinis, et al.. (2008). Design and synthesis of nitrate esters of aromatic heterocyclic compounds as pharmacological preconditioning agents. Bioorganic & Medicinal Chemistry. 16(8). 4523–4531. 11 indexed citations

11.

Tsotinis, Andrew, et al.. (2007). Design and Synthesis of New N-OMe Fluoro-Indole Melatoninergics. Medicinal Chemistry. 3(6). 561–571. 4 indexed citations

12.

Tsotinis, Andrew, et al.. (2007). Design and Synthesis of New N1 and C3-Substituted 4-Fluoroindolic Melatoninergics. Current Drug Discovery Technologies. 4(3). 198–207. 2 indexed citations

13.

Tsotinis, Andrew, et al.. (2007). C4-Substituted Isoquinolines: Synthesis and Cytotoxic Action. PubMed. 1(1). 1–3. 1 indexed citations

14.

Garratt, Peter J. & Andrew Tsotinis. (2007). Synthesis of Compounds as Melatonin Agonists and Antagonists. Mini-Reviews in Medicinal Chemistry. 7(10). 1075–1088. 26 indexed citations

15.

Tsotinis, Andrew, et al.. (2006). Design, synthesis and melatoninergic potency of new N-acyl 8,9-dihydro-4-methoxy-7H-2-benzo[de]quinolinalkanamines. Bioorganic Chemistry. 35(2). 189–204. 4 indexed citations

16.

Tsotinis, Andrew, et al.. (2003). Synthesis and biological evaluation of new β,β′-disubstituted 6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl ethylamido melatoninergic ligands. European Journal of Pharmaceutical Sciences. 18(5). 297–304. 7 indexed citations

17.

Tsotinis, Andrew, et al.. (2002). An expeditious synthesis of cytotoxic pyrroloisoquinoline derivatives.. European Journal of Pharmaceutical Sciences. 17(3). 139–143. 9 indexed citations

18.

Carbonnelle, Delphine, Catherine Jacquot, Gaëlle Le Dez, et al.. (2001). Up-regulation of a novel mRNA (NY-CO-1) involved in the methyl 4-methoxy-3-(3-methyl-2-butenoyl) benzoate (VT1)-induced proliferation arrest of a non-small-cell lung carcinoma cell line (NSCLC-N6). International Journal of Cancer. 92(3). 388–397. 8 indexed citations

19.

Tsotinis, Andrew, et al.. (2001). Synthesis of new tricyclic melatoninergic ligands. Il Farmaco. 56(9). 725–729. 10 indexed citations

20.

Faust, Rüdiger, Peter J. Garratt, Robert J. Jones, et al.. (2000). Mapping the Melatonin Receptor. 6. Melatonin Agonists and Antagonists Derived from 6H-Isoindolo[2,1-a]indoles, 5,6-Dihydroindolo[2,1-a]isoquinolines, and 6,7-Dihydro-5H-benzo[c]azepino[2,1-a]indoles. Journal of Medicinal Chemistry. 43(6). 1050–1061. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact